The European Investment Bank (EIB) has signed a €50 million loan to co-finance the R&D programme of Brainlab AG in 2023 and 2024. The loan comes with a guarantee from the European Fund for Strategic Investments (EFSI), also known as the Juncker Plan. The funding will support Brainlab’s R&D activities related to surgery, radiosurgery treatment and digital health.
Founded in 1989 and headquartered in Munich, Brainlab develops, manufactures and distributes hardware and software technology for computer-assisted medical procedures and their digitalisation. Its products focus on image-guided surgery, operation room integration, and radiosurgery in hospitals. The company achieves yearly revenues of about €360 million and employs 2 200 people.
Brainlab uses artificial intelligence (AI) to create highly detailed models of the brain, spine, breast and lung, which are integrated into surgery and radiosurgery tools. The company’s technology can be integrated with certain third-party medical technology devices. As such, it helps doctors and other clinicians to perform precision operations like brain surgery, and accurately track tumours that move with breathing when treating lung cancer with radiation therapy.
Germany: EIB to co-finance Brainlab Research & Development with €50 million loan